Zonisamide recalls
Zonisamide products have been recalled 5 times, most recently on 4 May 2022. The recalling company is usually Glenmark Pharmaceuticals Inc., U. The most common reason is manufacturing (cgmp) deviations.
Total recalls5since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 5 100%Class III 0 0%
Why zonisamide is recalled
Companies
By year
All zonisamide recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Zonisamide Capsules, USP, 100 mg recalled by Glenmark PharmaceuticalsZonisamide | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Zonisamide Capsules USP, 25 mg recalled by Glenmark PharmaceuticalsZonisamide | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Zonisamide Capsules, USP, 50 mg recalled by Glenmark PharmaceuticalsZonisamide | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Zonisamide Capsules USP 100 mg recalled by Glenmark PharmaceuticalsZonisamide | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Zonisamide Capsules USP 50 mg recalled by Glenmark PharmaceuticalsZonisamide | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.